Latest syllabus of C7010-010 is provided by killexams.com

killexams.com helps big numbers of check takers to obtain high marks within their exams plus achieve their professional goals. Simply signing up and downloading material will make a person sure you may pass your IBM Curam V6.0.4- Development along with high marks. C7010-010 braindumps are usually updated on a normal basis and down load is ready within your account, constantly.

Exam Code: C7010-010 Practice exam 2022 by Killexams.com team
C7010-010 IBM Curam V6.0.4, Development

The 6.0.5 product has reached its 5-year IBM Support limit. Therefore, the associated certification test will soon be retired. You are advised to take the V7 test, which will provide you with the skills required to work on V7 and earlier versions of Curam SPM.
This intermediate level certification is intended for Java developers who will work as Cúram developers for V6.0.4 and V6.0.5.
Recommended Prerequisite Skills
Before preparing for this certification, working knowledge of the following is recommended and assumed:
object-oriented concepts
Java
XML
SQL
n-tier enterprise applications
In preparing for this certification, the following IBM courses are highly recommended:
9D32G (or 9D44G): Fundamentals of the IBM Cúram SPM Platform for Developers V6.0.4 (or V6.0.5)
OR 9D40G (or 9D49G): Fundamentals of the IBM Cúram SPM Platform for Developers (ADE) V6.0.4 (SPVC) (or V6.0.5)
AND 9D41G (or 9D50G): Fundamentals of the IBM Cúram SPM Platform for Developers (Customization) V6.0.4 (SPVC) (or V6.0.5)

You may also consider taking one of the following courses to practice using IBM Cúram features: 9D46G (or 9D53G): IBM Cúram SPM Platform Development Environment 6.0.4 - Expert Arena (SPVC) (6.0.5)

IBM Curam V6.0.4, Development
IBM Development information source
Killexams : IBM Development information source - BingNews https://killexams.com/pass4sure/exam-detail/C7010-010 Search results Killexams : IBM Development information source - BingNews https://killexams.com/pass4sure/exam-detail/C7010-010 https://killexams.com/exam_list/IBM Killexams : Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

ReportLinker

Summary This latest Pharmaceutical and Healthcare disease pipeline guide Inclusion Body Myositis (IBM) - Drugs In Development, 2022, provides an overview of the Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline landscape.

New York, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update" - https://www.reportlinker.com/p06319569/?utm_source=GNW

Inclusion Body Myositis (IBM) is one of the inflammatory myopathies that involve inflammation of the muscles or associated tissues, such as the blood vessels that supply the muscles. IBM symptoms include progressive weakness of the muscles of the wrists and fingers, the muscles of the front of the thigh, and the muscles that lift the front of the foot.

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Inclusion Body Myositis (IBM) - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Inclusion Body Myositis (IBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 2, 3 and 2 respectively.

Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Inclusion Body Myositis (IBM) (Musculoskeletal Disorders).
- The pipeline guide reviews pipeline therapeutics for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders)

Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Read the full report: https://www.reportlinker.com/p06319569/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Sun, 25 Sep 2022 22:30:00 -0500 en-US text/html https://www.yahoo.com/now/inclusion-body-myositis-ibm-drugs-102700935.html
Killexams : Hispanic Heritage Foundation Announces Collaboration with IBM to Upskill Latinos Through IBM SkillsBuild and Meet America's Workforce Needs

The MarketWatch News Department was not involved in the creation of this content.

Program to prepare, certify and position Latinos for the future through tech ed and job skills

Oct 14, 2022 (3BL Media via COMTEX) -- SOURCE:IBM

DESCRIPTION:

WASHINGTON, October 14, 2022 /3BL Media/ - The Hispanic Heritage Foundation (HHF) announced today its collaboration with IBM (NYSE: IBM) which includes leveraging IBM SkillsBuild - a free education program that helps students and adult learners develop valuable new skills and access career opportunities in technology fields - by providing digital content, personalized mentoring, and the experiential learning they need to gain technical, critical thinking, and creative problem-solving skills. The program will be offered for FREE to HHF Network, is completely digital, and includes IBM-branded digital credentials that are recognized by the market to create direct pathways to tech jobs. The effort will be open to high school students, college students, young professionals, and adult learners.

"This IBM SkillsBuild collaboration has been a transformational goal of our tech pathways strategy and goal for years," said Jose Antonio Tijerino, President, and CEO of HHF. "Our community has a tremendous value proposition for America's workforce and through this innovative collaboration, America can benefit from the talent we have always had to offer. Our collective mission is to provide training and opportunities for our community to make an impact in the tech sector.

We are grateful to IBM for allowing us to leverage their expertise and pathways in preparing the Latinx community for jobs that desperately need to be filled. As Latinos, we're ready as we always have been."

The learning pathways available through IBM SkillsBuild include courses on workplace skills, such as communication and leadership skills designed for any beneficiary wishing to understand how to work in the digital world, as well as courses on data analytics, cybersecurity, cloud computing, and many other technical disciplines. The program will also help early school leavers and long-term unemployed to gain what is required to re-enter the workforce. Courses are available in English and Spanish, providing Hispanic learners with a better and deeper understanding of course materials, to help ensure completion and professional competency.

"As a Latina, I am very excited and honored to be partnering with the Hispanic Heritage Foundation to provide free education and career readiness resources to Hispanics nationwide," said Claudia Cortes Romanelli, Director of Corporate Social Responsibility at IBM. "I see every day the great opportunity to invest in skilling the next generation of STEM talent from the Hispanic community. We look forward to working with HHF as part of our commitment to equitably skill 30 million people worldwide."

The Hispanic Heritage Foundation award-winning LOFT (Latinos on Fast Track) program is a leadership and workforce development program and network with a focus on various sectors or "tracks," including tech. HHF's broad network and beyond will be exposed to IBM SkillsBuild to learn, and build skills in artificial intelligence, data science, cloud, security, information technology, and more, with opportunities for mentoring and networking in the tech space as well as earning certifications and placements into the workforce.

IBM and HHF's collaboration is part of IBM's commitment to equitably skill 30 million people globally by 2030.

About the Hispanic Heritage Foundation

HHF's mission focuses on education, the workforce, identity, and social impact through the lens of leadership and culture. For more information, visit www.hispanicheritage.org and follow the Hispanic Heritage Foundation on Instagram, Facebook, Twitter, and TikTok

About IBM Education

As part of the company's Corporate Social Responsibility efforts, IBM's education portfolio takes a personalized, diverse, and deep approach to STEM career readiness. IBM's pro bono programs range from education and support for teens at public schools and universities to career readiness resources for aspiring professionals and job seekers. IBM believes that education is best achieved through the collaboration of the public, private, and not-for-profit sectors.

IBM SkillsBuild is a free education program focused on underrepresented communities, that helps adult learners, and high school and university students and faculty, develop valuable new skills and access career opportunities. The program includes an online platform that is complemented by customized practical learning experiences delivered in collaboration with a global network of partners. The online platform offers over 1,000 courses in 19 languages on cybersecurity, data analysis, cloud computing, and many other technical disciplines -- as well as in workplace skills such as Design Thinking. Most importantly, participants can earn IBM-branded digital credentials recognized by the market. The customized practical learning experiences could include project-based learning, expert conversations with IBM volunteers and mentors, premium content, specialized support, connection with career opportunities, and access to IBM software. IBM SkillsBuild operates in 168 counties and has supported 2.2M learners.

Media Contact:

Estefania Sanchez
estefania.sanchez@ibm.com

Tweet me:.@IBMImpact announces collaboration with @hhfoundation to upskill Latinos through #IBMSkillsBuild as part of its commitment to equitably skill 30 million people globally by 2030: https://bit.ly/3CqDzMG #HispanicHeritageMonth

KEYWORDS: NYSE:IBM, IBM, Hispanic Heritage Foundation, skills development, IBM SkillsBuild

COMTEX_416626380/2551/2022-10-14T09:00:34

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Fri, 14 Oct 2022 01:00:00 -0500 en-US text/html https://www.marketwatch.com/press-release/hispanic-heritage-foundation-announces-collaboration-with-ibm-to-upskill-latinos-through-ibm-skillsbuild-and-meet-americas-workforce-needs-2022-10-14
Killexams : IBM veteran joins Red Hat C-suite in major executive shake-up No result found, try new keyword!Raleigh-based Red Hat is making key changes to its executive leadership as it gives its finance and operations organization a makeover. Thu, 13 Oct 2022 04:56:00 -0500 text/html https://www.bizjournals.com/charlotte/news/2022/10/13/red-hat-ibm-executive-leadership-changes.html Killexams : IBM Streamlines Red Hat Storage Products Within the IBM Storage Business Unit

IBM announced it will add Red Hat storage product roadmaps and Red Hat associate teams to the IBM Storage business unit, bringing consistent application and data storage across on-premises infrastructure and cloud.

With the move, IBM will integrate the storage technologies from Red Hat OpenShift Data Foundation (ODF) as the foundation for IBM Spectrum Fusion. This combines IBM and Red Hat's container storage technologies for data services and helps accelerate IBM's capabilities in the burgeoning Kubernetes platform market.

In addition, IBM intends to offer new Ceph solutions delivering a unified and software defined storage platform that bridges the architectural divide between the data center and cloud providers. This further advances IBM's leadership in the software defined storage and Kubernetes platform markets, according to the vendor.

"Red Hat and IBM have been working closely for many years, and today's announcement enhances our partnership and streamlines our portfolios," said Denis Kennelly, general manager of IBM Storage, IBM Systems. "By bringing together the teams and integrating our products under one roof, we are accelerating the IBM's hybrid cloud storage strategy while maintaining commitments to Red Hat customers and the open-source community."

Benefits of the software defined portfolio available from IBM will include:

  • A unified storage experience for all containerized apps running on Red Hat OpenShift: Customers can use IBM Spectrum Fusion (now with Red Hat OpenShift Data Foundation) to achieve the highest levels of performance, scale, automation, data protection, and data security for production applications running on OpenShift that require block, file, and/or object access to data. This enables development teams to focus on the apps, not the ops, with infrastructure-as-code designed for simplified, automated managing and provisioning.
  • A consistent hybrid cloud experience at enterprise levels of scale and resiliency with IBM Ceph: Customers can deliver their private and hybrid cloud architectures on IBM's unified and software defined storage solution, providing capacity and management features. Capabilities include data protection, disaster recovery, high availability, security, auto-scaling, and self-healing portability, that are not tied to hardware, and travel with the data as it moves between on-premises and cloud environments.
  • A single data lakehouse to aggregate and derive intelligence from unstructured data on IBM Spectrum Scale: Customers can address the challenges that often come with quickly scaling a centralized data approach with a single platform to support data-intensive workloads such as AI/ML, high performance computing, and others. Benefits can include less time and effort to administer, reduced data movement and redundancy, direct access to data for analytics tools, advanced schema management and data governance, all supported by distributed file and object storage engineered to be cost effective.
  • Build in the cloud, deploy on-premises with automation: Customers can move developed applications from the cloud to on-premises services, automate the creation of staging environments to test deployment procedures, validate configuration changes, database schema and data updates, and ready package updates to overcome obstacles in production or correct errors before they become a problem that affects business operations.

"Red Hat and IBM have a shared belief in the mission of hybrid cloud-native storage and its potential to help customers transform their applications and data," said Joe Fernandes, vice president of hybrid platforms, Red Hat. "With IBM Storage taking stewardship of Red Hat Ceph Storage and OpenShift Data Foundation, IBM will help accelerate open-source storage innovation and expand the market opportunity beyond what each of us could deliver on our own. We believe this is a clear win for customers who can gain a more comprehensive platform with new hybrid cloud-native storage capabilities."

Under the agreement between IBM and Red Hat, IBM will assume Premier Sponsorship of the Ceph Foundation, whose members collaborate to drive innovation, development, marketing, and community events for the Ceph open-source project.

IBM Ceph and Red Hat OpenShift Data Foundation will remain 100% open source and will continue to follow an upstream-first model, reinforcing IBM's commitment to these vital communities, according to the company.

Red Hat and IBM intend to complete the transition by January 1, 2023, which will involve the transfer of storage roadmaps and Red Hat associates to the IBM Storage business unit.

Following this date, Red Hat OpenShift Platform Plus will continue to include OpenShift Data Foundation, sold by Red Hat and its partners.

Additionally, Red Hat OpenStack customers will still be able to buy Red Hat Ceph Storage from Red Hat and its partners. Red Hat OpenShift and Red Hat OpenStack customers with existing subscriptions will be able to maintain and grow their storage footprints as needed, with no change in their Red Hat relationship.

Forthcoming IBM Ceph and IBM Spectrum Fusion storage solutions based on Ceph are expected to ship beginning in the first half of 2023.

For more information about this news, visit www.ibm.com.


Tue, 04 Oct 2022 02:03:00 -0500 en text/html https://www.dbta.com/Editorial/News-Flashes/IBM-Streamlines-Red-Hat-Storage-Products-Within-the-IBM-Storage-Business-Unit-155227.aspx
Killexams : View from India: Quantum computing’s amazing potential

There is growing interest and investment in quantum computing, but we’ve just about touched the tip of the proverbial iceberg. It could take a while before the potential of this technology is fully harnessed for new drug discoveries, scientific explorations and more.

An image of the penicillin molecule may be difficult to analyse, let alone molecules with over 100 components. This is where quantum computing fits in. It has a unique ability to calculate structures at atomic and subatomic scales and does so with precision. That’s just one of its attributes. No surprise that the technology could find applications in communication satellites that can be beamed to receivers on Earth. This may be used for scientific studies. That’s not all. Quantum computing may be used in healthcare, communication and large-scale optimisation like traffic flow, goods delivery and task simulation. It could probably help to sift through large chunks of data related to climate or population.

Given this diversity, the government and private companies are investing in this technology for research and commercial applications. Start-ups too can scout for opportunities in software, hardware and manufacturing of smaller parts. The 2020 Union Budget earmarked 8,000 crore (80 billion) rupees (£860m) for quantum technology research over the next five years.

The Ministry of Electronics and Information Technology (MeitY) had also announced a collaboration with Amazon Web Services (AWS) to develop a Quantum Computing Applications Lab. A quantum computing laboratory and an AI centre at a military engineering institute at Mhow, Madhya Pradesh has been established by the Indian Army. Last year, the Indian government launched Quantum Simulator (QSim) devices that are meant for studying quantum effects, which may be difficult to pursue in a lab. This is for developers, scientists and students to research on quantum computing. The platform has been built by Indian Institute of Sciences (IISc), Bangalore, Indian Institute of Technology (IIT), Roorkee, and the Centre for Development of Advanced Computing (C-DAC). Browsers can sign in from anywhere through qctoolkit.com. Google too has announced a similar QSim last year. IBM has come up with initiatives such as IBM Quantum Challenge, IBM Quantum Summer School and Qiskit Challenge-India. Qiskit is IBM’s open-source software development kit. Honeywell and Boeing offer cloud simulations of quantum computing.

Hopefully these efforts will trigger off new studies in the technology. The next thing that comes to mind is quantum computers, which are far removed from the regular classical computers. Standard computers store information as binary 0 and 1states. The quantum computing analogue of classical computer bits is qubit or quantum bits. A qubit can be in a combination of states. This differentiator gives it an extra mileage which can be utilised for deducing large calculations.

Quantum computers may not replace the classical ones. They could collaborate with classical computers to solve computational problems. The algorithms from quantum computers could be used to measure and understand the gaps in the classical computers.

An intrinsic feature of quantum computers is that they need to be kept cold, much colder than the surrounding area. It would take a lot of engineering and tweaking to Excellerate the technology and build large-scale quantum computers and implement themto understand the structure of molecules and new materials. “The real challenge today is not to build a quantum computer and show that it can work (it does)…however, to scale up the technology and build large-scale, super quantum computers,” said Shohini Ghose, Wilfrid Laurier University, speaking at the Keysight World Innovate event held virtually. 

Not just that, quantum computers are based on quantum mechanics and quantum uncertainty, which can be used functionally. To supply an example, it may not be possible to know about every single property, movement and location of an electron or atom. Quantum uncertainty by its very nature can be applied to create a computing model for getting insights into the electron or atom. By doing so, the landscape of computing expands and may be used to tackle security threats. “If you wish to hide information from eavesdroppers, quantum computing can be used to encode information on the quantum data. When one particulate and quantum bits interact, they can get locked together. Jointly they have a connection and their co-relation may be tapped to develop a new kind of compute protocols and calculations,” added Ghose, an award-winning quantum physicist who threw light on the basics of quantum computing, its promise, its dangers, and what to expect from it in the future.

The process of quantum computing involves teleportation. In simple terms, quantum teleportation happens when quantum information is transferred from source to destination through entangled states. “Quantum teleporting is mind-boggling. The teleport qubits may open up avenues in quantum internet, networking and matters related to privacy and confidentiality,” reasoned Jeff Harris, vice president, portfolio and corporate marketing at Keysight Technologies.

Quantum computing can impact various sections of the society, it can be a social impact revolution. But then, somewhere people could make a beginning and this may become a use case for others to emulate. As in the case of other technologies, there are bottlenecks here too. “Performance, scalability and up-time are among the three technical challenges of quantum computing. We design products based on the three parameters to solve various issues. We are in the process of creating the next-gen quantum engineers by grooming them on YouTube and through partnership initiatives,” explained Giampaolo Tardioli, vice president, communications solutions group, Keysight Technologies. 

Decades-long hype around quantum systems probably still exists. Yet it could offer near and far-term potential. But then technical challenges may have to be overcome for quantum systems to realise their promise in fields spanning cyber-security, materials creation, financial analysis and military receivers.

Sign up to the E&T News e-mail to get great stories like this delivered to your inbox every day.

Sun, 16 Oct 2022 22:55:00 -0500 en-US text/html https://eandt.theiet.org/content/articles/2022/10/view-from-india-teleportation-healthcare-much-more-key-takeaways-of-quantum-computing/
Killexams : Axiado to Demo New Smart Secure Control Module Technology at OCP Global Summit No result found, try new keyword!Executive leadership from Axiado will be available at the OpenPOWER Foundation (OPF) booth #C32 at the OCP Global Summit in San Jose, Calif., October 18-20, to demo their Smart SCM security hardware ... Mon, 17 Oct 2022 02:36:00 -0500 en-US text/html https://it.tmcnet.com/news/2022/10/17/9693538.htm Killexams : Data Historian Market Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast to 2029 By VMR

The MarketWatch News Department was not involved in the creation of this content.

Oct 13, 2022 (Heraldkeepers) -- New Jersey, United States,- The Data Historian Market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Data Historian report also incorporates the current and future global market outlooks in emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.

The Data Historian research report also provides insights of different regions that are contributing to market growth. It also includes the competitive landscape that involves leading companies and adopting strategies to announce partnerships and collaboration to contribute to market growth.

Request PDF demo Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.verifiedmarketreports.com/download-sample/?rid=498273

The research study includes profiles of leading companies operating in the Data Historian Market:

ABB, AVEVA Group, General Electric, Honeywell, IBM, Siemens, Yokogawa, Aspen Technology, Emerson, PTC, Rockwell Automation, ICONICS, OSIsoft, Automsoft, Canary Labs, COPA-DATA

The study report offers a comprehensive analysis of Data Historian Market size across the globe as regional and country-level market size analysis, CAGR estimation of market growth during the forecast period, revenue, key drivers, competitive background, and sales analysis of the payers. Along with that, the report explains the major challenges and risks to face in the forecast period. Data Historian Market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Data Historian Market will be able to gain the upper hand as they use the report as a powerful resource.

This report also covers Analysis based on SWOT Analysis, providing the Strengths, Weaknesses, Opportunities, and Threats for a better understanding of the market. Also, the Porter Five Forces Model for the Global Data Historian Market will be provided.

Data Historian Market, By Type:

? On-Premises
? Cloud

Data Historian Market, By Application:

? Oil and Gas
? Marine
? Chemicals and Pharmaceuticals
? Paper and Pulp
? Metals and Mining
? Utilities
? Data Centers
? Others

Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=498273

Regional Analysis Covered in this report:

? North America (USA and Canada)
? Europe (UK, Germany, France and the rest of Europe)
? Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
? Latin America (Brazil, Mexico, and the rest of Latin America)
? Middle East and Africa (GCC and rest of the Middle East and Africa)

Reasons Why You Should Buy This Report:

? To gain an in-depth understanding of the Data Historian Market
? To obtain research-based business decisions and add weight to presentations and marketing strategies
? To gain competitive knowledge of leading market players
? It gives a pinpoint investigation of changing rivalry elements and keeps you in front of contenders.
? It helps in settling on educated business choices by having total bits of knowledge of the market and by making inside and out an investigation of market sections.

Table of Contents:

1. Introduction of the Global Data Historian Market
? Overview of the Market
? Scope of Report
? Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Reports
? Data Mining
? Validation
? Primary Interviews
? List of Data Sources

4. Global Data Historian Market Outlook
? Overview
? Market Dynamics
? Drivers
? Restraints
? Opportunities
? Porters Five Force Model
? Value Chain Analysis

5. Global Data Historian Market, By Product

6. Global Data Historian Market, By Application

7. Global Data Historian Market, By Geography
? North America
? Europe
? Asia Pacific
? Rest of the World

8. Global Data Historian Market Competitive Landscape
? Overview
? Company Market Ranking
? Key Development Strategies

9. Company Profiles

10. Appendix

For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/data-historian-market-szie-and-forecast/

About Us: Verified Market Reports

Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies.

We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Our research spans over a multitude of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages etc. Having serviced many Fortune 2000 organizations, we bring a rich and reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll-Free: +1 (800)-782-1768

The post Data Historian Market Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast to 2029 By VMR appeared first on Herald Keeper.

COMTEX_416586941/2582/2022-10-13T23:14:26

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Thu, 13 Oct 2022 15:14:00 -0500 en-US text/html https://www.marketwatch.com/press-release/data-historian-market-analysis-business-development-size-share-trends-future-growth-forecast-to-2029-by-vmr-2022-10-13
Killexams : Statistics Centre Abu Dhabi taps IBM Turbonomic to accelerate their digital footprint in the region

More than 3000 automated actions executed, saving over 500 hours of manual work.

Cairo, Egypt: Statistics Centre - Abu Dhabi (SCAD) and IBM discussed boosting cooperation to fuel SCAD’s growth, accelerate digital footprint and drive sustainable development across various operations. The collaboration enables SCAD to leverage IBM® Turbonomic® Application Resource Management (ARM) to automate processes, optimize digital infrastructure performance and minimize costs.

SCAD is responsible for building an information network and a unified channel that serves the statistical ecosystem in Abu Dhabi by organizing, unifying, and managing all aspects of the Emirate's statistical data. SCAD develops a leading statistical ecosystem to empower decision makers and users in the government, private sector, and society.

SCAD selected IBM Turbonomic to scale intelligent automation capabilities to run across any hybrid cloud environment. Over the duration of three months, IBM Turbonomic executed over 3,000 automated actions, including continuous placement for virtual machines, containers, and scaling infrastructure resource saving SCAD more than 500 hours of manual work with a projected expectation to save 2,000 hours over 2023.

The partnership between SCAD and IBM is aligned with efforts to reach a balance between carbon neutrality and application performance. Through leveraging IBM Turbonomic, SCAD will be able to minimize energy consumption and reduce carbon footprint by 17 tonnes.

Aziz Hmoud Saif Alkayyoomi, Acting Director of Information Technology at SCAD, said: “We are focused on leveraging the latest emerging technologies that provide reliable and high-quality statistics, analysis and research that support sustainable development processes and Excellerate user experience across Abu Dhabi. Our collaboration with IBM is an important step to create a leading statistical ecosystem that empowers decision-makers in both the public and private sectors.”

Wael Abdoush, General Manager, IBM Gulf, Levant, and Pakistan, said: “We are pleased to partner with SCAD to provide a one-stop shop of AI-powered automation capabilities, all built on Red Hat OpenShift to run anywhere. IBM designs, deploys, and manages energy efficient infrastructures and innovations with a hybrid cloud approach. Our collaboration with SCAD paves the way for SCAD to achieve sustainable development goals and deliver the most efficient use of computing, storage, and network resources,” he added.

About SCAD

The Statistics Centre – Abu Dhabi (SCAD) was established by Law No. (7) of 2008 to organize and develop statistical work in the Emirate of Abu Dhabi. The SCAD’s role has been reregulated in 2021 and started to report to the Abu Dhabi Executive Office. It adopted a decentralized methodology in statistical work, in order to support decision-makers and entrepreneurs to devise strategic plans and policies and advance Abu Dhabi’s comprehensive and sustainable development.

SCAD has an independent legal personality and full financial independence, as well as full legal capacity to work in line with the Emirate's directions towards achieving sustainable economic and social development goals and the Abu Dhabi Economic Vision 2030, under the supervision of the Abu Dhabi Executive Council.

Based on the law amendment, SCAD is now responsible for building a unified system for Abu Dhabi’s statistical information and unifying and managing all aspects of statistical work in the Emirate. This includes development and regulation of statistical frames for all activities and sectors and updating them periodically, as well as providing technical supervision of statistical work and data systems at government entities. That, in addition to collecting, classifying, storing, analyzing, processing, archiving, publishing, and protecting Abu Dhabi's statistical data obtained from various data sources.

SCAD is also responsible for making, developing, and disseminating estimates, projections, extrapolations, and forecasts. Additionally, the Centre is tasked with supporting government entities and transferring knowledge and expertise, thereby enabling them to provide reliable and accurate statistics. SCAD is also authorized to contract with any entity or company within or outside the Emirate to undertake data collection and other statistical activities.

About IBM

IBM is a leading global hybrid cloud and AI, and business services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,800 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM's hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently, and securely. IBM's breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM's legendary commitment to trust, transparency, responsibility, inclusivity, and service. For more information, visit www.ibm.com

Thu, 13 Oct 2022 15:34:00 -0500 en text/html https://www.zawya.com/en/press-release/government-news/statistics-centre-abu-dhabi-taps-ibm-turbonomic-to-accelerate-their-digital-footprint-in-the-region-oreeqtrt
Killexams : Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

ReportLinker

Summary This latest Pharmaceutical and Healthcare disease pipeline guide Inclusion Body Myositis (IBM) - Drugs In Development, 2022, provides an overview of the Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline landscape.

New York, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update" - https://www.reportlinker.com/p06319569/?utm_source=GNW

Inclusion Body Myositis (IBM) is one of the inflammatory myopathies that involve inflammation of the muscles or associated tissues, such as the blood vessels that supply the muscles. IBM symptoms include progressive weakness of the muscles of the wrists and fingers, the muscles of the front of the thigh, and the muscles that lift the front of the foot.

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Inclusion Body Myositis (IBM) - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Inclusion Body Myositis (IBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 2, 3 and 2 respectively.

Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Inclusion Body Myositis (IBM) (Musculoskeletal Disorders).
- The pipeline guide reviews pipeline therapeutics for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders)

Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Read the full report: https://www.reportlinker.com/p06319569/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Sun, 25 Sep 2022 22:30:00 -0500 en-GB text/html https://uk.finance.yahoo.com/news/inclusion-body-myositis-ibm-drugs-102700552.html
C7010-010 exam dump and training guide direct download
Training Exams List